Avantor Inc (AVTR) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Total Assets Chart for Avantor Inc
Avantor Inc (AVTR) total assets for FY2025 were USD 11.8B, a -2.6% change from FY2024. Avantor Inc's total assets grew from USD 1.1B in 2016 to USD 11.8B in 2025 (938.4% over 9 years). Total assets compound annual growth rate: 5-year CAGR of 3.6%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $10.38B
- Implied Share Price
- $15.35
- Enterprise Value
- $13.37B
- Revenue (TTM)
- $6.56B
- EBITDA
- $943.70M
- Profit Margin
- -8.81%
- Trailing P/E
- —
- Forward P/E
- 16.86
- Price/Book (MRQ)
- 1.77
- Price/Sales (TTM)
- 1.58
- EV/EBITDA
- 118.46
- EV/Revenue
- 2.04
- Dividend Yield
- —
- Book Value
- $8.32
- Free Cash Flow (FY2025)
- $495.00M
- Free Cash Flow Yield
- 4.77%
Snapshot as of 8th October 2026 — not point-in-time controlled, may lag the live market by a few days.